Anzeige
Mehr »
Donnerstag, 16.07.2026 - Börsentäglich über 12.000 News
Wenn nationale Sicherheit in den Vorstandsetagen ankommt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
190 Leser
Artikel bewerten:
(1)

Fundação GIMM - Gulbenkian Institute for Molecular Medicine: GIMM Festival brings leading microbiology experts to Lisbon to discuss emerging viruses, antimicrobial resistance and biological engineering

Charles M. Rice (2020 Nobel Prize in Medicine), Bonnie Bassler, Yasmine Belkaid and Isabel Gordo are among the confirmed speakers.

LISBON, Portugal, July 16, 2026 /PRNewswire/ -- Bacteria are continuously evolving and becoming increasingly resistant to life-saving medicines. Understanding how microorganisms adapt, communicate and influence human health is now a global scientific priority. This will be one of the central themes of the second edition of the GIMM Festival, taking place in Lisbon from 17 to 19 September.

Under the theme 'Microbes - The Questions of the Future', the festival will bring together internationally renowned researchers to explore the role of microorganisms in human health, biological evolution and ecosystem sustainability. The event aims to foster dialogue between science, society and biomedical innovation, at a time when challenges such as pandemics, antimicrobial resistance and environmental change are raising urgent new questions for research and policy.

The programme features some of the most influential names in contemporary microbiology:

  • Charles M. Rice (Rockefeller University), Nobel Prize winner in Medicine (2020), whose work led to the identification of the hepatitis C virus and enabled the development of effective antiviral treatments;
  • Yasmine Belkaid, President of the Institut Pasteur, recognised for her pioneering research on the microbiome and immune system interactions;
  • Bonnie Bassler (Princeton University), a leading expert in quorum sensing, the chemical communication process used by bacteria;
  • Isabel Gordo (GIMM), ERC Advanced Grant recipient, who studies bacterial evolution within the human body and the mechanisms behind antibiotic resistance.

Over three days, researchers and the public will engage in discussions on major scientific challenges of the 21st century, including host-microbe interactions and disease, antimicrobial resistance and bacterial evolution, emerging viruses and preparedness for future pandemics, as well as microorganism engineering and synthetic biology.

Antimicrobial resistance is considered by the World Health Organization one of the greatest threats to global health, with the potential to cause millions of deaths in the coming decades if no effective action is taken. At the same time, advances in microbiome research and the growing capacity to engineer microorganisms are transforming fields such as medicine, biotechnology and environmental sustainability, opening new possibilities for prevention, diagnosis and treatment.

"The microscopic world has a profound impact on our health, ecosystems and the future of biotechnology. The GIMM Festival aims to bring researchers and society closer together to discuss how these discoveries can shape the future," says Maria Manuel Mota, CEO of the Gulbenkian Institute for Molecular Medicine.

With the participation of world-leading scientists, including a Nobel laureate, the GIMM Festival positions Lisbon as an international hub for scientific debate, reinforcing its role as a meeting point for cutting-edge research and innovation in microbiology and global health.

The full programme and registration are available at www.gimmfest.pt.

About the Gulbenkian Institute for Molecular Medicine (GIMM)
The Gulbenkian Institute for Molecular Medicine (GIMM) is a biomedical research institute created through the merger of the Instituto Gulbenkian de Ciência (IGC) and the Instituto de Medicina Molecular João Lobo Antunes (iMM). With a strong commitment to advancing knowledge, developing innovative solutions for health and translating discoveries into real-world impact, GIMM aims to establish itself as a global leader in life sciences and biomedical research.
www.gimm.pt

About the GIMM Festival
The GIMM Festival is an annual event in Lisbon that celebrates science as a driver of social transformation. Organised by GIMM, it brings together national and international experts to discuss the major challenges of global health, promoting the connection between cutting-edge research, biomedical innovation and society.
www.gimmfest.pt

Press Contacts
Rita Resendes -
Communications & Media Relations Manager, Fundação GIMM?
rita.resendes@gimm.pt
+351 916 519 630

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/gimm-festival-brings-leading-microbiology-experts-to-lisbon-to-discuss-emerging-viruses-antimicrobial-resistance-and-biological-engineering-302826363.html

© 2026 PR Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.